Immunological detection of Nω-(carboxymethyl)arginine by a specific antibody

Annals of the New York Academy of Sciences

Volumn 1126, Issue , 2008, Pages 155-157

  Mera, Katsumi ^a,b   Fujiwara, Yukio ^b   Otagiri, Masaki ^a   Sakata, Noriyuki ^c   Nagai, Ryoji ^b  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Advanced glycation end products; Atherosclerosis; Diabetes; Monoclonal antibody; N (carboxymethyl)arginine

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ARGININE DERIVATIVE; CYSTEINE DERIVATIVE; LYSINE DERIVATIVE;

ADULT; AGED; AGING; ANIMAL CELL; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ATHEROSCLEROSIS; CONFERENCE PAPER; CROSS REACTION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY;

EID: 42549093992     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1433.000     Document Type: Conference Paper

References (10)

1. 1 Yamada, K. et al. 1994. Immunohistochemical study of human advanced glycosylation end‐products (AGE) in chronic renal failure. Clin. Nephrol. 42: 354–361.
2. 2 Kume, S. et al. 1995. Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody. Am. J. Pathol. 147: 654–667.
3. 3 Miyata, T. et al. 1996. Identification of pentosidine as a native structure for advanced glycation end products in beta‐2‐microglobulin‐containing amyloid fibrils in patients with dialysis‐related amyloidosis. Proc. Natl. Acad. Sci. USA 93: 2353–2358.
4. 4 Mizutari, K. et al. 1997. Photo‐enhanced modification of human skin elastin in actinic elastosis by N(epsilon)‐(carboxymethyl)lysine, one of the glycoxidation products of the Maillard reaction. J. Invest. Dermatol. 108: 797–802.
5. 5 Degenhardt, T.P. et al. 2002. Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin‐diabetic rat. Kidney Int. 61: 939–950.
6. 6 Iijima, K. et al. 2000. Identification of N(omega)‐carboxymethylarginine as a novel acid‐labileadvanced glycation end product in collagen. Biochem. J. 347: 23–27.
7. 7 Odani, H. et al. 2001. Identification of N(omega)‐carboxymethylarginine, a new advanced glycation endproduct in serum proteins of diabetic patients: possibility of a new marker of aging and diabetes. Biochem. Biophys. Res. Commun. 285: 1232–1236.
8. 8 Fu, MX. et al. 1996. The advanced glycation end product, Nepsilon‐(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. J. Biol. Chem. 271: 9982–9986
9. 9 Jono, T. et al. 2004. Nepsilon‐(Carboxymethyl)lysine and 3‐DG‐imidazolone are major AGE structures in protein modification by 3‐deoxyglucosone. J. Biochem. (Tokyo) 136: 351–358.
10. 10 Mera, K. et al. 2007. Hypochlorous acid generates N epsilon‐(carboxymethyl)lysine from Amadori products. Free Radic. Res. 41: 713–718.